Skip to main content

FORMULARY COVERAGE TOOL

Coverage Tool to Support
with Treatment Access

Not an actual patient.

Not an actual patient.

96

%

of commercially insured patients
nationally are covered for DUPIXENT1,a,b

76

%

of commercially insured patients nationally
have coverage for DUPIXENT
without requirements
for trial of swallowed topical corticosteroids (STC)
1,a,b

THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR EoE PATIENTS
AS YOUNG AS 1 YEAR WEIGHING ≥15 kg

aMMIT data as of March 2026. FUN documents and Policy Reporter updates as of April 2026.

bCoverage varies by type and plan.

The formulary status tool below can help check DUPIXENT coverage for various plans.
Contact the health plan or DUPIXENT MyWay® to verify coverage for a specific patient.

icon search

Check the formulary status for DUPIXENT in your area

See coverage status, prior authorization, and step therapy information

US.DUP.26.06.0052

QUESTIONS?

You and your patients
can contact
DUPIXENT MyWay®
at 1-844-DUPIXEN(T)
(1-844-387-4936)
,
Monday-Friday,
8am-9pm ET